HCSGD entry for SPRED1


1. General information

Official gene symbolSPRED1
Entrez ID161742
Gene full namesprouty-related, EVH1 domain containing 1
Other gene symbolsNFLS hSpred1 spred-1
Links to Entrez GeneLinks to Entrez Gene

2. Neighbors in the network

color bar
This gene isn't in PPI subnetwork.

3. Gene ontology annotation

GO ID

GO term

Evidence

Category

GO:0000188Inactivation of MAPK activityIEA ISSbiological_process
GO:0005173Stem cell factor receptor bindingIEA ISSmolecular_function
GO:0005515Protein bindingIPImolecular_function
GO:0005634NucleusIDAcellular_component
GO:0005730NucleolusIDAcellular_component
GO:0005737CytoplasmIDAcellular_component
GO:0005886Plasma membraneIDAcellular_component
GO:0005901CaveolaIEAcellular_component
GO:0007275Multicellular organismal developmentIEAbiological_process
GO:0010801Negative regulation of peptidyl-threonine phosphorylationIEA IMPbiological_process
GO:0010923Negative regulation of phosphatase activityIDAbiological_process
GO:0019901Protein kinase bindingIEA IPImolecular_function
GO:0019902Phosphatase bindingIDAmolecular_function
GO:0030291Protein serine/threonine kinase inhibitor activityIEA ISSmolecular_function
GO:0043517Positive regulation of DNA damage response, signal transduction by p53 class mediatorIEA ISSbiological_process
GO:0090311Regulation of protein deacetylationIEA ISSbiological_process
Entries Per Page
Displaying Page of

4. Expression levels in datasets

  • Meta-analysis result

p-value upp-value downFDR upFDR down
0.00892370350.97356314730.24220020581.0000000000

  • Individual experiment result
    ( "-" represent NA in the specific microarray platform )

Data sourceUp or downLog fold change
GSE11954Up0.4552201501
GSE13712_SHEARUp0.5859734140
GSE13712_STATICUp0.4676277316
GSE19018Down-0.2067179077
GSE19899_A1Up0.5613268747
GSE19899_A2Up0.4743357059
PubMed_21979375_A1Up0.5691762079
PubMed_21979375_A2Up0.4211442213
GSE35957Up0.1222463963
GSE36640Up0.2586795025
GSE54402Up0.7596715054
GSE9593Up0.6172937874
GSE43922Down-0.0434517750
GSE24585Up0.2763525779
GSE37065Down-0.0152637389
GSE28863_A1Up0.5681671587
GSE28863_A2Up0.4703436831
GSE28863_A3Down-0.3319180350
GSE28863_A4Up0.2169320992
GSE48662Down-0.5126696125

5. Regulation relationships with compounds/drugs/microRNAs

  • Compounds

Not regulated by compounds

  • Drugs

Not regulated by drugs

  • MicroRNAs

    • mirTarBase

MiRNA_name

mirBase ID

miRTarBase ID

Experiment

Support type

References (Pubmed ID)

hsa-miR-126-3pMIMAT0000445MIRT000343Luciferase reporter assay//Western blotFunctional MTI18987025
hsa-miR-126-3pMIMAT0000445MIRT000343Luciferase reporter assayFunctional MTI18694566
hsa-miR-126-3pMIMAT0000445MIRT000343Luciferase reporter assayNon-Functional MTI18832181
hsa-miR-126-3pMIMAT0000445MIRT000343Flow//Luciferase reporter assay//qRT-PCR//Western blotFunctional MTI22525256
hsa-miR-335-5pMIMAT0000765MIRT018666MicroarrayFunctional MTI (Weak)18185580
hsa-miR-375MIMAT0000728MIRT019967MicroarrayFunctional MTI (Weak)20215506
hsa-miR-132-3pMIMAT0000426MIRT021849MicroarrayFunctional MTI (Weak)17612493
hsa-miR-103a-3pMIMAT0000101MIRT027190SequencingFunctional MTI (Weak)20371350
hsa-miR-93-5pMIMAT0000093MIRT028118SequencingFunctional MTI (Weak)20371350
hsa-miR-16-5pMIMAT0000069MIRT031930SequencingFunctional MTI (Weak)20371350
Entries Per Page
Displaying Page of
    • mirRecord
No target information from mirRecord

6. Text-mining results about the gene

Gene occurances in abstracts of cellular senescence-associated articles: 1 abstracts the gene occurs.


PubMed ID of the article

Sentenece the gene occurs

26943583A three-pronged approach has been adopted to assess the if adalimumab is able to: i) modulate a panel of classic and novel senescence- and SASP-associated markers (interleukin [IL]-6, senescence associated-beta-galactosidase, p16/Ink4a, plasminogen activator inhibitor 1, endothelial nitric oxide synthase, miR-146a-5p/Irak1 and miR-126-3p/Spred1) in human umbilical vein endothelial cells (HUVECs); ii) reduce the paracrine effects of senescent HUVECs' secretome on MCF-7 breast cancer cells, through wound healing and mammosphere assay; and iii) exert significant decrease of miR-146a-5p and increase of miR-126-3p in circulating angiogenic cells (CACs) from psoriasis patients receiving adalimumab in monotherapy
Entries Per Page
Displaying Page of